Posted: Tue Jan 20, 2009 12:40 pm Post subject: Catalent to Present at West Coast Meeting of Parenteral Drug
Catalent to Present at West Coast Meeting of Parenteral Drug Association (PDA)
Released on: January 20, 2009, 1:45 am
Press Release Author: Dan Dunlop
Press Release Summary: Members of Catalent's Respiratory, Analytical and Biotechnology Group will participate in the Parenteral Drug Association (PDA) West Coast Chapter’s panel discussion titled “Challenges and Best Practices in Extractable and Leachables” on January 22, 2009.
Press Release Body: Research Triangle Park, N.C. – January 19, 2009 – Patty Kiang, Ph.D., Catalent’s Account Director for Analytical & Biotech Services in its Northern C.A./Pacific Northwest territory, and Tom Feinberg, Ph.D., Catalent’s Director, Structural Chemistry will both participate in the Parenteral Drug Association (PDA) West Coast Chapter’s panel discussion titled “Challenges and Best Practices in Extractable and Leachables.” The panel is part of the Chapter’s 2009 Professional Dinner Meeting Series.
Kiang, who has served in the past as a faculty member of the Parenteral Drug Association’s (PDA) Training and Research Institute, will moderate the evening’s discussion. Feinberg, a member of the PQRI Leachables & Extractables Working Group, is scheduled to deliver a presentation titled: “Future of Extractables and Leachables Regulatory Expectations - A PQRI Process Update.” Both Kiang and Feinberg work within Catalent’s Respiratory, Analytical and Biotechnology Group, with sites in Research Triangle Park, N.C., San Diego, C.A. and Middleton, W.I.
The PDA event will be held January 22 at 6pm in South San Francisco. Additional information about the 2009 Dinner Meeting Series and this panel discussion can be found at www.wccpda.org.
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,500 at more than 30 facilities worldwide and generates more than $1.8 billion of annual revenue. For more information, visit www.catalent.com.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum